Re: Executive cognitive deficits in primary dystonia

Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research.

Journal of reward deficiency syndrome·2015

Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.

Journal of neuroimmunology·2011

Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients.

Journal of neuroimmunology·2011

Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans.

Autoimmunity·2010

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

Movement disorders : official journal of the Movement Disorder Society·2005

Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells.

Movement disorders : official journal of the Movement Disorder Society·2026

Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.

Movement disorders : official journal of the Movement Disorder Society·2026

Rare Heterozygous Loss-of-Function Variants in MCOLN1 Identified in Two Sporadic Patients with α-Synucleinopathies.

Movement disorders : official journal of the Movement Disorder Society·2026

Real-World Evaluation of Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Essential Tremor.

Movement disorders : official journal of the Movement Disorder Society·2026

Epilepsy-Dyskinesia Syndromes: The Venn Diagram of Genetic Epilepsy and Movement Disorders.

Movement disorders : official journal of the Movement Disorder Society·2026

A Gap Analysis of Deep Brain Stimulation for Childhood-Onset Movement Disorders.

Movement disorders : official journal of the Movement Disorder Society·2026

Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities.

Molecular biology reports·2026

Association of dopamine transporter gene DAT1 40-bp 3' UTR VNTR polymorphism (rs28363170) with Psychiatric disorders susceptibility: A study from the Pakistani population.

Molecular biology reports·2026

Cerebellar ataxia in the Philippines: a scoping review of reported cases and practical approach.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Nucleostemin promotes RAD51 filament assembly on double-stranded DNA to protect stalled replication forks.

Nucleic acids research·2026

Relationship between neck weakness in motor neurone disease and respiratory function: a retrospective study.

Neurodegenerative disease management·2026

Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis.

Experimental animals·2026

Related Experiment Videos

Re: Executive cognitive deficits in primary dystonia

Related Concept Videos

Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research.

Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.

Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients.

Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans.

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells.

Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.

Rare Heterozygous Loss-of-Function Variants in MCOLN1 Identified in Two Sporadic Patients with α-Synucleinopathies.

Real-World Evaluation of Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Essential Tremor.

Epilepsy-Dyskinesia Syndromes: The Venn Diagram of Genetic Epilepsy and Movement Disorders.

A Gap Analysis of Deep Brain Stimulation for Childhood-Onset Movement Disorders.

Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities.

Association of dopamine transporter gene DAT1 40-bp 3' UTR VNTR polymorphism (rs28363170) with Psychiatric disorders susceptibility: A study from the Pakistani population.

Cerebellar ataxia in the Philippines: a scoping review of reported cases and practical approach.

Nucleostemin promotes RAD51 filament assembly on double-stranded DNA to protect stalled replication forks.

Relationship between neck weakness in motor neurone disease and respiratory function: a retrospective study.

Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis.

Related Experiment Videos

Re: Executive cognitive deficits in primary dystonia

Related Concept Videos

Related Articles